Rethinking large hospital business models

Monday, December 14, 2020 3:00 PM to 5:00 PM · 2 hr. (Africa/Abidjan)

Information

Traditional business models are being challenged by large hospital groups – public and private. Increasingly, they are taking ownership of wider activities in areas such as prevention and chronic disease management. They are also expanding their reach into the deployment of AI, digital health and wider medical research activities. 



This session looks at the strategies they are adopting and the implications for healthcare ecosystems. 

The session is part of the wider HBI event but is by invitation only. This includes CEOs of many of the large hospital systems who come to London every year to attend the event. They include most of the major for-profit groups in Europe and Emerging Markets as well as several large US academic medical centres

Perspectives on the future:


Three short presentations will be followed by Q&A on the implications of these changes. 

Three challenges for big hospital systems


Dr Ian Abbs, Chief Executive and Chief Medical Officer, Guy’s and St Thomas’ NHS Foundation


Ian talks about how GSTT is bringing together its capabilities from three university hospitals, an academic centre and a new research hub with AI and machine learning. He looks at three critical areas: how to scale up without losing nimbleness, how to best build wider partnerships which include competitors, and how hospitals and research centres can extract cost savings from new technology such as AI in partnership with medtech. 

Transforming hospital services


Dr Ronnie van der Merwe, CEO, Mediclinic International


Mediclinic (2018 revenue US$3.8bn) is the largest for-profit hospital chain in Switzerland and the GCC as well as one of the big three players in South Africa. Here Ronnie talks about how Mediclinic did two things: introduced much better governance at a major GCC acquisition and secondly moved its Swiss operation, Hirslanden, towards a new and much lower cost outpatient model. What were the challenges and lessons from these journeys?

Radical hospital and digital reform – the Danish experience


Henrik Schodts, Chairman, Nordic Health Lab, Deputy Chief Executive / Chief Innovation Officer, Nordsjaellands Hospital



16:00 - 17:00
CEO Roundtable discussion


Participants are invited to attend a one-hour roundtable discussion with 8-10 people in each group. With no Powerpoint presentations and a democratic choice on topics this is a rare opportunity to share learnings and issues. 


1. Developing effective strategy plans for hospitals.

Discuss the barriers to building effective strategies, How to get stakeholder input, and how to reach a clear consensus whilst retaining stakeholder consent through strategy implementation.

2. Coping with Covid

An opportunity to share experiences and explore future challenges. What worked and what didn't, What are the strategies and technologies going forwards, How do you build staff resilience and morale?

3. Beyond the hospital

Many new hospitals are far smaller than their predecessors with much of the activity shifted to outpatient and home settings. This session will discuss the group's experience of this process? How do you manage the shift to outpatient? How do you best handle the move to home? What impact will Covid have on hospital sizes?

4. How to handle transformation

Hospital business models are changing fast as we move towards outpatient, the home, digital solutions, the deployment of AI and big data and closer integration with social care. Here we will look at the challenge’s participants have faced and what techniques work best to change attitudes and achieve the groups objectives.

 The Rethinking Large Hospital Business Models CEO seminar is part of the wider HBI 2020 virtual conference but limited to invited participants only, including CEOs of many of the largest for-profit groups in Europe and Emerging Markets as well as several large non-for-profit groups and US academic medical centres.

AbbottAbbott is a global healthcare leader that helps people live more fully at all stages of life through life-changing technologies and products that span prevention, diagnosis andtreatment. These include:     Diagnostics, including tests and instrument systems for hospitals and labs, blood banks and clinics; patient-side blood testing; and sophisticated information solutions that enable faster and better decisions across the health system     Medical devices, including advanced technologies to keep hearts and arteries healthy, to treat chronic pain and movement disorders, and to give people with diabetes more freedom to manage their glucose levels without painful fingersticks    Nutrition products, built on science, to help build and maintain health from infancy onward    Branded generic medicines, high-quality, trusted brands that we market only in emerging markets outside the United States  Our work is driven by a basic idea: When people are at their healthiest, they have the potential to live longer and better. So, we focus on innovations that help people get and stay healthy so they can live their best lives.  We’re revolutionizing health with the most personal technologies, empowering people with the data and knowledge they need to help them live longer and better. Our connected-care and digital-health tools are helping people make better, faster and more complete decisions about their health in ways that fit easily into their lives and keep them connected to their doctors.    Abbott has been improving people’s health for more than 130 years. Today, more than 100,000 of us are advancing the state of healthcare for millions of people around the world. We're always looking to the future, anticipating changes in medical science and technology, ensuring our portfolio is relevant to where our markets and customers are heading. 

Log in